Through Calls for Proposals, we find smart new ideas to help to alleviate the burden of diseases such as HIV/AIDS, tuberculosis and malaria, which often affect the poorest people in society.
Unitaid aims to improve cure rates for people affected by MDR TB by addressing concrete challenges where measurable impact may be achieved, using technologies that are available (or soon will be) in a targeted timeframe, and filling concrete gaps in the global response. Through extensive outreach and consultations with TB stakeholders, Unitaid has worked to understand the evolving challenges and identify potential opportunities that could align with its strategy and model – with a focus on those with potential to provide significant improvements to the lives of people affected by MDR TB.
Under this Call, Unitaid is soliciting proposals for the following interventions aimed at accelerating the availability, adoption and scale-up of improved tools to identify severe disease.
The use of Long Lasting Insecticidal Nets (LLINs) accounts for 69 percent of the malaria cases averted since 2001. But increasing insecticide resistance threatens these gains. Together with the Global Fund and the President's Malaria Initiative, Unitaid is seeking proposals to gather evidence and to implement pilot studies to demonstrate the added value of next-generation insecticidal nets.
Within the patent system, several mechanisms exist to overcome patent barriers, notably the use of “TRIPS flexibilities”, such as compulsory licensing, a transition period for the least-developed countries, patent oppositions and stringent patentability criteria. This approach can play an important role in facilitating access to medicines.
This Call is focused on accelerating access to better, faster and more robust DR-TB treatment with corresponding diagnostic needs.